However, when insulin resistance develops, phosphatidylinositol 3 kinase-nitric oxide (P13K-NO) activity decreases [10], resulting in impaired downstream eNOS activity characteristic of endothelial dysfunction, and leads to diminished NO bioavailability [11,12,13]. Here, NOS3 is linked to endothelial dysfunction.